IntrinsicIntrinsic
← Scroll for more →

Financial Statements — HIVE

Balance Sheet

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q2 2024Q4 2023Q4 2022Q4 2021
Cash & Equivalents208.0423.1114.0723.389.8522.6424.609.687.244.375.3240.29
Total Current Assets280.0359.8590.86245.30310.26136.67180.65185.23203.5282.49200.30107.54
Total Assets924.64639.15624.00531.60--692.97628.73----------
Total Current Liabilities143.0554.4452.2965.9629.8153.6152.8127.3536.6321.8926.159.86
Total Liabilities501.94109.7964.7282.46--68.3768.21----------
Retained Earnings(565.22)(422.31)(345.97)(273.86)(351.01)(254.64)(238.85)(347.87)(352.28)(296.67)(60.24)(130.63)
Total Stockholder Equity422.70529.36559.27449.14434.36624.60560.52259.69279.53148.82389.05134.47
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2027Q3 2026Q3 2025Q2 2025Q1 2025Q2 2024
Interest Expense0.440.24--0.150.07--
Pretax Income----1.39----(7.34)
Tax Provision1.580.500.121.020.650.32
Net Income(142.91)(91.33)1.27(15.80)35.02(7.66)
Basic EPS(0.54)(0.38)0.01(0.07)0.19(0.06)
Diluted EPS(0.54)(0.38)0.01(0.07)0.18(0.06)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2027Q3 2026Q3 2025Q2 2025Q1 2025Q2 2024
Operating Cash Flow4.0645.60(23.60)(0.38)10.23(5.02)
Capital Expenditures14.75----------
Free Cash Flow*(10.69)----------
Investing Cash Flow(48.12)(175.88)(90.46)(108.10)(61.96)(27.97)
Financing Cash Flow228.56120.55114.33107.3352.8530.50
← Scroll for more columns →

* Derived from reported values